( January 22, 2026, 10:05 AM EST) -- NEW ORLEANS — Generic manufacturers of a chemotherapy drug that allegedly caused eye injuries could not unilaterally change their labels because they lacked any “newly acquired information” about the danger of the drugs, making claims against them preempted by federal law, the Louisiana federal judge overseeing multidistrict litigation ruled....